Hurler syndrome surgery: Difference between revisions

Jump to navigation Jump to search
Line 7: Line 7:
[[Bone marrow transplantation]] (BMT) and [[umbilical cord blood transplantation]] (UCBT) can successfully treat the mucopolysaccharidoses. Abnormal physical characteristics, except for those affecting the skeleton and eyes, can be improved, and neurologic degeneration can often be halted. BMT and UCBT are high-risk procedures with high rates of morbidity and mortality. However, they are the only treatments that have the potential to cure the disease.
[[Bone marrow transplantation]] (BMT) and [[umbilical cord blood transplantation]] (UCBT) can successfully treat the mucopolysaccharidoses. Abnormal physical characteristics, except for those affecting the skeleton and eyes, can be improved, and neurologic degeneration can often be halted. BMT and UCBT are high-risk procedures with high rates of morbidity and mortality. However, they are the only treatments that have the potential to cure the disease.
==Surgery==
==Surgery==
===Bone Marrow Transplantation and Umbilical Cord Blood Transplantation===
===Bone Marrow Transplantation ===
* These procedures lead to replacement of mutated/ non-functional cells of the bone marrow with functional cells.
* These procedures lead to replacement of mutated/ non-functional cells of the bone marrow with functional cells.
* Functional new cells act as a source for the deficient enzyme.
* Functional new cells act as a source for the deficient enzyme.

Revision as of 03:49, 26 February 2013

Hurler Syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hurler Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hurler syndrome surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hurler syndrome surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hurler syndrome surgery

CDC on Hurler syndrome surgery

Hurler syndrome surgery in the news

Blogs on Hurler syndrome surgery

Directions to Hospitals Treating Hurler syndrome

Risk calculators and risk factors for Hurler syndrome surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Bone marrow transplantation (BMT) and umbilical cord blood transplantation (UCBT) can successfully treat the mucopolysaccharidoses. Abnormal physical characteristics, except for those affecting the skeleton and eyes, can be improved, and neurologic degeneration can often be halted. BMT and UCBT are high-risk procedures with high rates of morbidity and mortality. However, they are the only treatments that have the potential to cure the disease.

Surgery

Bone Marrow Transplantation

  • These procedures lead to replacement of mutated/ non-functional cells of the bone marrow with functional cells.
  • Functional new cells act as a source for the deficient enzyme.
  • Transplant has the best outcome when its done as soon as the diagnosis is established.
  • Children who receive a transplant early enough can have normal or near-normal mental development.
  • If the disease has progressed causing organ damage, the child is at high risk of developing life-threatening complications from transplant.
  • Transplants cannot undo the damage done to nervous system.
  • Risks of transplant

References